Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). (Q37352471)
Jump to navigation
Jump to search
scientific article published on 29 June 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). |
scientific article published on 29 June 2009 |
Statements
1 reference
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). (English)
1 reference
Martin S Tallman
1 reference
Elisabeth Paietta
1 reference
Peter L Greenberg
1 reference
Zhuoxin Sun
1 reference
Kenneth B Miller
1 reference
John M Bennett
1 reference
Gordon Dewald
1 reference
Richard van der Jagt
1 reference
Jessie Houston
1 reference
Mary L Thomas
1 reference
David Cella
1 reference
Jacob M Rowe
1 reference
29 June 2009
1 reference
1 reference
2393-2400
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference